Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [644]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
CITATION STYLE
Breyer, R. M., Clapp, L., Coleman, R. A., Giembycz, M., Heinemann, A., Hills, R., … Yao, C. (2019). Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). https://doi.org/10.2218/gtopdb/f58/2019.4
Mendeley helps you to discover research relevant for your work.